Russia is trying to close down a plague scare before it becomes an international health crisis, but its assurances have not resolved questions about how a laboratory worker died or what happened inside the Siberian facility.

The dispute centers on Darya Shipilova, a technician at the Irkutsk Anti-Plague Research Institute who died on Oct. 2 after developing severe pneumonia. Russian officials say her death was caused by “pneumonia of unknown etiology” and deny that she contracted pneumonic plague. The country’s health regulator also rejected reports of a second case as “fake information circulating on social media,” saying nearly 5,000 tests found no dangerous pathogens among contacts.¹

Moscow’s position is therefore built around containment and closure: authorities say roughly 200 people were initially monitored, 90 percent had been released, and no infection was detected among those exposed. In Washington, the response has been similarly restrained. President Donald Trump said, “We don’t think so” when asked whether a bioweapon was involved, while U.S. officials described the risk to Americans as extremely low and reported no sign of a broader threat.²

The WHO, however, has taken a more skeptical stance—not by asserting that plague occurred, but by stressing that the available evidence is insufficient. It said it still does not know what caused the death and pressed Russia for “timely, complete and transparent information sharing” before a full risk assessment can be made.³

China pledged cooperation with Russia on infectious-disease control, while medical experts cited concerns that limited transparency could itself increase public-health risks.⁴ The central contrast is clear: Russian and U.S. officials emphasize the absence of evidence for an outbreak, whereas the WHO and outside experts emphasize the consequences of not having enough information to independently verify that conclusion.